| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 25 |
| 1 | RITUXIMAB | 21 |
| 2 | CYCLOPHOSPHAMIDE | 20 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 20 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 20 |
| 5 | ETOPOSIDE | 18 |
| 6 | DOXORUBICIN | 14 |
| 7 | METHOTREXATE | 11 |
| 8 | METHOTREXATE SODIUM | 11 |
| 9 | AXICABTAGENE CILOLEUCEL | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 9 | 0.0009 |
| 1 | BLEOMYCIN SULFATE | 8 | 0.0008 |
| 2 | VINORELBINE | 5 | 0.0007 |
| 3 | POLATUZUMAB VEDOTIN | 4 | 0.0004 |
| 4 | IFOSFAMIDE FOR INJECTION | 7 | 0.0003 |
| 5 | ETOPOSIDE | 18 | 0.0002 |
| 6 | BLINATUMOMAB | 2 | 0.0002 |
| 7 | FLUDARABINE PHOSPHATE | 7 | 0.0002 |
| 8 | DOXORUBICIN | 14 | 0.0002 |
| 9 | MESNA INJECTION | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 9 | 0.0009 |
| 1 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 2 | Alkylating Drug [EPC] | 25 | 0.0001 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 21 | 0.0001 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 5 | 0.0001 |
| 5 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 7 | Corticosteroid [EPC] | 26 | 0.0000 |
| 8 | Antirheumatic Agent [EPC] | 2 | 0.0000 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |